Cargando…

Development and Validation of Prognostic Nomogram for Young Patients with Kidney Cancer

BACKGROUND: The aim of this study was to establish a nomogram model to evaluate the prognosis of early-onset kidney cancer (EOKC) in terms of overall survival (OS) and cancer-specific survival (CSS). METHODS: Patients with EOKC diagnosed between 2004 and 2015 were collected from Surveillance, Epidem...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Shengwei, Sun, Si, Mao, Weipu, Qian, Siwei, Zhang, Lei, Zhang, Guangyuan, Xu, Bin, Chen, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420796/
https://www.ncbi.nlm.nih.gov/pubmed/34511991
http://dx.doi.org/10.2147/IJGM.S331627
_version_ 1783748951087775744
author Tian, Shengwei
Sun, Si
Mao, Weipu
Qian, Siwei
Zhang, Lei
Zhang, Guangyuan
Xu, Bin
Chen, Ming
author_facet Tian, Shengwei
Sun, Si
Mao, Weipu
Qian, Siwei
Zhang, Lei
Zhang, Guangyuan
Xu, Bin
Chen, Ming
author_sort Tian, Shengwei
collection PubMed
description BACKGROUND: The aim of this study was to establish a nomogram model to evaluate the prognosis of early-onset kidney cancer (EOKC) in terms of overall survival (OS) and cancer-specific survival (CSS). METHODS: Patients with EOKC diagnosed between 2004 and 2015 were collected from Surveillance, Epidemiology and End Results (SEER) and randomly assigned to the training and validation set at a ratio of 2 to 1. Important variables for constructing nomograms were screened by univariate and multivariate Cox analysis. The nomogram model was evaluated using concordance index (C-index), decision curve analysis (DCA) curves, and receiver operating characteristic (ROC) curves. RESULTS: A total of 12,526 EOKC patients were included in the study. OS nomogram was constructed based on gender, age, race, grade, AJCC stage, TNM stage, histology, chemotherapy and radiotherapy. CSS nomogram was constructed based on listed above except gender. In the external validation, the C-index for the OS nomogram was 0.855 (95% CI 0.834–0.976), and the C-index for the CSS nomogram was 0.938 (0.925–0.951). High-quality calibration curves were noted in both OS and CSS nomogram models. ROC and DCA curves showed that nomograms had better predictive performance than TNM stage and SEER stage. CONCLUSION: The nomogram model provides an applicable tool for evaluating the OS and CSS prognosis of EOKC.
format Online
Article
Text
id pubmed-8420796
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84207962021-09-09 Development and Validation of Prognostic Nomogram for Young Patients with Kidney Cancer Tian, Shengwei Sun, Si Mao, Weipu Qian, Siwei Zhang, Lei Zhang, Guangyuan Xu, Bin Chen, Ming Int J Gen Med Original Research BACKGROUND: The aim of this study was to establish a nomogram model to evaluate the prognosis of early-onset kidney cancer (EOKC) in terms of overall survival (OS) and cancer-specific survival (CSS). METHODS: Patients with EOKC diagnosed between 2004 and 2015 were collected from Surveillance, Epidemiology and End Results (SEER) and randomly assigned to the training and validation set at a ratio of 2 to 1. Important variables for constructing nomograms were screened by univariate and multivariate Cox analysis. The nomogram model was evaluated using concordance index (C-index), decision curve analysis (DCA) curves, and receiver operating characteristic (ROC) curves. RESULTS: A total of 12,526 EOKC patients were included in the study. OS nomogram was constructed based on gender, age, race, grade, AJCC stage, TNM stage, histology, chemotherapy and radiotherapy. CSS nomogram was constructed based on listed above except gender. In the external validation, the C-index for the OS nomogram was 0.855 (95% CI 0.834–0.976), and the C-index for the CSS nomogram was 0.938 (0.925–0.951). High-quality calibration curves were noted in both OS and CSS nomogram models. ROC and DCA curves showed that nomograms had better predictive performance than TNM stage and SEER stage. CONCLUSION: The nomogram model provides an applicable tool for evaluating the OS and CSS prognosis of EOKC. Dove 2021-09-01 /pmc/articles/PMC8420796/ /pubmed/34511991 http://dx.doi.org/10.2147/IJGM.S331627 Text en © 2021 Tian et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Tian, Shengwei
Sun, Si
Mao, Weipu
Qian, Siwei
Zhang, Lei
Zhang, Guangyuan
Xu, Bin
Chen, Ming
Development and Validation of Prognostic Nomogram for Young Patients with Kidney Cancer
title Development and Validation of Prognostic Nomogram for Young Patients with Kidney Cancer
title_full Development and Validation of Prognostic Nomogram for Young Patients with Kidney Cancer
title_fullStr Development and Validation of Prognostic Nomogram for Young Patients with Kidney Cancer
title_full_unstemmed Development and Validation of Prognostic Nomogram for Young Patients with Kidney Cancer
title_short Development and Validation of Prognostic Nomogram for Young Patients with Kidney Cancer
title_sort development and validation of prognostic nomogram for young patients with kidney cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420796/
https://www.ncbi.nlm.nih.gov/pubmed/34511991
http://dx.doi.org/10.2147/IJGM.S331627
work_keys_str_mv AT tianshengwei developmentandvalidationofprognosticnomogramforyoungpatientswithkidneycancer
AT sunsi developmentandvalidationofprognosticnomogramforyoungpatientswithkidneycancer
AT maoweipu developmentandvalidationofprognosticnomogramforyoungpatientswithkidneycancer
AT qiansiwei developmentandvalidationofprognosticnomogramforyoungpatientswithkidneycancer
AT zhanglei developmentandvalidationofprognosticnomogramforyoungpatientswithkidneycancer
AT zhangguangyuan developmentandvalidationofprognosticnomogramforyoungpatientswithkidneycancer
AT xubin developmentandvalidationofprognosticnomogramforyoungpatientswithkidneycancer
AT chenming developmentandvalidationofprognosticnomogramforyoungpatientswithkidneycancer